GeneDx Holdings (WGS) stock surged over 46% on Tuesday after the genetic testing company reported impressive third-quarter earnings that beat expectations. The company’s revenue skyrocketed, driven by robust growth in exome and genome testing, leading to positive adjusted net income and an optimistic outlook for 2024.
U.S. stocks closed higher on Tuesday, with the Dow Jones index gaining around 50 points, driven by a wave of strong earnings reports from companies like Corning, GeneDx, and V.F. Corporation. These companies exceeded expectations and boosted investor confidence, propelling their stock prices higher. This positive momentum extended to other sectors, highlighting the overall bullish sentiment in the market.
